IL12A binds IL12B

Stable Identifier
R-HSA-8950113
Type
Reaction [uncertain]
Species
Homo sapiens
Compartment
Synonyms
Interleukin-12 subunit alpha binds Interleukin-12 subunit beta by protein disulfide isomerase
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

The Interleukin-12 heterodimer (IL-12) is formed by Interleukin-12 subunit alpha (IL12A, IL-12p35) and Interleukin-12 subunit beta (IL12B, IL-12p40) (Podlaski et al. 1992, Kobayashi et al. 1989, Stern et al.1990). Heterodimerization occurs due to charged residue interactions (Yoon et al. 2000) and is stabilized by disulfide bounding.
IL12 heterodimerization is believed to occur in the endoplasmic reticulum (ER) because inhibition of the enzyme Prolyl 4-hydroxylase subunit beta (P4HB), referred to in this article as Protein disulfide isomerase (PDI), by bacitracin causes IL-12 retention in the ER (Alloza & Vandenbroek 2005).

Literature References
PubMed ID Title Journal Year
1347984 Molecular characterization of interleukin 12

Podlaski, FJ, Nanduri, VB, Hulmes, JD, Pan, YC, Levin, W, Danho, W, Chizzonite, R, Gately, MK, Stern, AS

Arch. Biochem. Biophys. 1992
10899108 Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12

Yoon, C, Johnston, SC, Tang, J, Stahl, M, Tobin, JF, Somers, WS

EMBO J 2000
15720785 The metallopeptide antibiotic bacitracin inhibits interleukin-12 alphabeta and beta2 secretion

Alloza, I, Vandenbroeck, K

J. Pharm. Pharmacol. 2005
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
protein disulfide isomerase activity of P4HB [endoplasmic reticulum lumen]
Physical Entity
Activity
Authored
Reviewed
Created